Trials / Completed
CompletedNCT03486925
Oxytocin Effect on Attention Inhibition
An Eye-tracking Study to Investigate Oxytocin Effect on Attention Inhibition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Effects of intranasal oxytocin (24IU) on cognitive control of attention
Detailed description
The cognitive control of attention towards neutral and emotional stimuli represents a key functional domain and disruptions in this domain have been associated with a range of psychiatric disorders. Saccadic eye movement tasks have been used to assess individual differences in the cognitive control of attention and alterations in psychiatric disorders. Recent evidence suggests that the hypothalamic neuropeptide Oxytocin (OXT) may modulate attention allocation and regulation. To this end the present randomized between-subject placebo-controlled experiment examined whether intranasal OXT modulates behavior in an eye-tracking saccade / anti-saccade paradigm in healthy male subjects. The paradigm used non-social (neutral shape) as well as social (happy, sad, angry, fear, and neutral faces) stimuli to explore emotion-specific effects of OXT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxytocin treatment | intranasal administration of oxytocin (24IU) |
| DRUG | placebo treatment | intranasal administration of placebo |
Timeline
- Start date
- 2017-12-19
- Primary completion
- 2018-07-20
- Completion
- 2018-08-28
- First posted
- 2018-04-03
- Last updated
- 2019-03-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03486925. Inclusion in this directory is not an endorsement.